Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: Augmenting Cerebral Blood Flow in Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial to augment cerebral blood flow in acute ischemic stroke is not yet recruiting, sponsored by the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Stroke | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING